Artemis Medicare Services growth over the years

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Compounded a year	1 yr	3 yr
Revenue	+15.4%	+13.6%
EBITDA	+24.0%	+26.0%
Net Income	+26.2%	+39.7%
EPS (adj.)	+25.4%	+42.4%
Total Assets	+5.3%	+16.4%
Total Equity	+11.5%	+32.1%
Free Cash Flow	−48.6%	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ARTEMISMED₹297.95

Artemis Medicare Services Limited

· Pharma & Health

₹ CrorePeersINDRAMEDCO SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹4,717 Cr

Annuals · FY-end closes

Compounded Growth Annuals · CAGR %	1Y CAGR	3Y CAGR
Revenue	+15.4	+13.6
EBITDA	+24.0	+26.0
Net Income	+26.2	+39.7
EPS (adj.)	+25.4	+42.4
Total Assets	+5.3	+16.4
Total Equity	+11.5	+32.1
Free Cash Flow	-48.6	—

CAGR from filed annuals — needs positive start & end values.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.